"We have long admired Komodo's achievements and we believe the company's unique approach has finally linked robust patient journey data with crucial workflows to achieve greater efficiency and better outcomes in healthcare," said Caroline Xie, General Partner, ICONIQ Growth. "With the acquisition of Mavens, Komodo extends its strategy deeper into the life sciences enterprise and remains well capitalized to accelerate its impact across the entire healthcare ecosystem."
About Komodo Health
Komodo Health believes that smarter, more innovative use of data and analytics is essential for reducing disease burden. We apply artificial intelligence and other advanced data science techniques to our first-of-its-kind Healthcare Map™, which tracks the unique patient journeys of over 320 million patients. We empower a multitude of healthcare stakeholders – life science companies, healthcare payers and providers, patient advocacy groups, and others – to create a more cost-effective, value-driven healthcare system. For more information, visit www.komodohealth.com.
About Mavens
Mavens is the pioneer in building trusted software products and implementing cloud-based technology to help biotech, rare disease, and specialty pharma companies navigate the challenges of commercialization. The company was founded by two Salesforce alumni – Prasad Kanumury (PK) and Billy Ho – with a simple goal to demystify and unlock the power of cloud technology for life sciences. The Mavens team has designed, built, and implemented globally compliant software in life sciences for more than 13 years.
Back to HCB News
